Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
30 participants
INTERVENTIONAL
2008-05-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Virtual Reality Device for Rehabilitation of Stroke Patients
NCT04139980
Effectiveness of IVR Combined With Task-Specific Training on Hemiplegic Arm Function Following Stroke
NCT05728866
Efficacy of Recreational-therapeutic Use of Video Games on the Emotional State of Stroke Patients
NCT05143385
Immersive Virtual Reality for Stroke Motor Rehabilitation
NCT03094650
The Effects of Video Games in Stroke
NCT03896542
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Design: Randomized-matched, single-blind, control group cross-over study Setting: Laboratory Patients: Participants with chronic hemiparesis post-stroke were randomly assigned to a gaming group or normal activity control group.
Interventions: Gaming systems provided an interactive interface of real-time movement of either themselves or an avatar on the screen. Participants played games 1 hour/day, 4 days/week, for 5 weeks, totaling 20 hours of game-play. The intervention was strictly game-play without physical therapy. All games were played in standing position and trainers supervised to protect against loss of balance.
Measurements: Both groups were tested prior to and following the 5 weeks (post-test) and 3 months following the completion of the intervention/control. Outcome measures included: Fugl-Meyer Motor Exam, Single Leg Stance time, symmetrical weight bearing, Berg Balance Scale, Dynamic Gait Index, Timed Up and Go, Six Minute Walk, 3 Meter Walk, step length differential, and perception of recovery.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate Treatment Group
Commercially-Available Interactive Video Games
Two commercially available gaming platforms were used in this study, the Nintendo Wii and the Sony PS 2. The Wii games included "Wii Sports" and "Wii Fit"; PS games included the EyeToy "Play 2" and "Kinetic". Each of these games provides multiple mini games which pose different movement challenges, including dynamic balance, speed, accuracy, general mobility, and weight shifts.
Game play was performed 1 hour/day, 4 days/ week, for a period of 5 weeks, totaling 20 hours.
Delayed Treatment Group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Commercially-Available Interactive Video Games
Two commercially available gaming platforms were used in this study, the Nintendo Wii and the Sony PS 2. The Wii games included "Wii Sports" and "Wii Fit"; PS games included the EyeToy "Play 2" and "Kinetic". Each of these games provides multiple mini games which pose different movement challenges, including dynamic balance, speed, accuracy, general mobility, and weight shifts.
Game play was performed 1 hour/day, 4 days/ week, for a period of 5 weeks, totaling 20 hours.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to walk 10 feet with or without assistance
* 18 years of age or older
* Clinical presentation of unilateral hemiplegia post-stroke
* Ability to follow simple two-step instructions
Exclusion Criteria
* History of serious chronic obstructive pulmonary disease or oxygen dependence
* Severe weight bearing pain
* Lower-extremity amputation
* Non-healing ulcers on the lower extremity
* Renal dialysis or end stage liver disease
* Legal blindness or deafness or severe visual or hearing impairment
* A history of significant psychiatric illness defined by diagnosis of bipolar affective disorder, psychosis, or schizophrenia
* Life expectancy less than one year
* Severe arthritis or orthopaedic problems that limit passive ranges of motion of lower extremity: Knee flexion contracture of -10 degrees, Knee flexion ROM \< 90 degrees, hip flexion contracture \> 25 degrees, ankle plantar flexion contracture \> 15 degrees
* History of deep venous thrombosis or pulmonary embolism within 6 months
* Uncontrollable diabetes: diabetic coma, frequent insulin reactions
* Severe hypertension with systolic \> 200mmHg and diastolic \> 110mmHg at rest
* Intracranial hemorrhage related to aneurysm rupture or an arteriovenous malformation (hemorrhagic infarctions will not be excluded)
* History of severe seizure disorder; other neurological conditions such as multiple sclerosis or Parkinson's Disease
* Pain that is scored greater than 5 out of 10 on a visual analog scale and limits daily activity
* Any health problems judged by their screening physician to put the client at significant risk of harm during the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of South Carolina
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Stacy Fritz
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stacy L Fritz, PhD
Role: PRINCIPAL_INVESTIGATOR
University of South Carolina
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of South Carolina - Public Health Research Building
Columbia, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
University of South Carolina Rehabilitation Lab Website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00001904
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.